Skip to main content

and
  1. No Access

    Article

    Specific self-antigen-driven immune response in pericardial effusion as an isolated GVHD manifestation

    Pericardial effusion and cardiac tamponade have been described as GVHD manifestations in the post transplant period. Direct evidence of GVHD-related TCR or B-cell receptor clones in patients with pericardial e...

    A Lev, N Amariglio, Z Spirer, U Katz, B Bielorai, G Rechavi in Bone Marrow Transplantation (2010)

  2. No Access

    Article

    Interferon-γ-induced neuronal differentiation of human umbilical cord blood-derived progenitors

    Human umbilical cord blood (HUCB) provides a source of progenitors for cell therapy. We isolated and characterized an HUCB-derived population of progenitors (HUCBNP), differentiated toward neuronal phenotype b...

    H Arien-Zakay, S Lecht, M M Bercu, N Amariglio, G Rechavi, H Galski in Leukemia (2009)

  3. No Access

    Article

    The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation

    The chemokine stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, participate in the retention of acute myeloblastic leukemia (AML) cells within the bone marrow microenvironment and their release in...

    S Tavor, M Eisenbach, J Jacob-Hirsch, T Golan, I Petit, K BenZion, S Kay in Leukemia (2008)

  4. No Access

    Article

    The presence of a single PML-RARA isoform lacking exon 5 in FISH-negative APL samples

    O Ashur-Fabian, L Trakhtenbrot, D Dominissini, M Koren-Michowitz, A Nagler in Leukemia (2008)

  5. No Access

    Article

    High-throughput, sensitive and quantitative assay for the detection of BCR-ABL kinase domain mutations

    A Vivante, N Amariglio, M Koren-Michowitz, O Ashur-Fabian, A Nagler, G Rechavi in Leukemia (2007)

  6. No Access

    Article

    Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells

    Tumors contain a fraction of cancer stem cells that maintain the propagation of the disease. The CD34+CD38− cells, isolated from acute myeloid leukemia (AML), were shown to be enriched leukemic stem cells (LSC...

    H Gal, N Amariglio, L Trakhtenbrot, J Jacob-Hirsh, O Margalit, A Avigdor in Leukemia (2006)

  7. No Access

    Article

    Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients

    Successful stem cell transplantation for patients with severe combined immunodeficiency (SCID) from matched family donors without conditioning results in engraftment of T lymphocytes. B lymphocytes engraft in ...

    B Bielorai, L Trakhtenbrot, N Amariglio, R Rothman, U Tabori in Bone Marrow Transplantation (2004)

  8. No Access

    Article

    Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF

    Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is frequently used to mobilize CD34+ cells in healthy donors and patient with malignant diseases prior to peripheral blood stem cell (PBSC) har...

    C Kaplinsky, L Trakhtenbrot, I Hardan, M Reichart, M Daniely in Bone Marrow Transplantation (2003)

  9. No Access

    Article

    B-cell lymphoma develo** in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation

    Donor-cell leukemia post bone marrow transplantation is a rare event. Most of the cases reported to date have developed in cells from an HLA-matched sibling, who had no evidence of malignant disease before or ...

    B Bielorai, H J Deeg, M Weintraub, Y Neumann, E Rosner in Bone Marrow Transplantation (2003)

  10. No Access

    Article

    Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the bioView (Duet™) combined morphological and cytogenetical analysis

    Recurrent disease remains a major obstacle to cure after allogeneic transplantation. Various methods have been developed to detect minimal residual disease (MRD) after transplantation to identify patients at r...

    A Shimoni, A Nagler, C Kaplinsky, M Reichart, A Avigdor, I Hardan, M Yeshurun in Leukemia (2002)

  11. No Access

    Article

    CMV reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantation

    Hemorrhagic cystitis (HC) is a known complication of stem cell transplantation. In contrast to early-onset HC that is usually attributed to cyclophosphamide and occurs within a few days of infusion, late onset...

    B Bielorai, LM Shulman, G Rechavi, A Toren in Bone Marrow Transplantation (2001)

  12. No Access

    Article

    The clinical and biological dilemma of preleukemia presenting as aplastic anemia with chromosomal translocation t(4;11)

    U Tabori, Y Burstein, R Dvir, G Rechavi, A Toren in Leukemia (2001)

  13. No Access

    Article

    Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation

    Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder characterized by impaired microbial killing and susceptibility to bacterial and fungal infections. Cure of the disease can be achieved...

    B Bielorai, A Toren, B Wolach, M Mandel, H Golan, Y Neumann in Bone Marrow Transplantation (2000)

  14. No Access

    Article

    Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency

    A 2-month-old girl with severe combined immunodeficiency (SCID), presented with mild staphylococcal skin infection, lymphopenia, low T cell number, absence of B cells, high number of NK cells, and a negligible...

    A Toren, A Nagler, N Amariglio, Y Neumann, H Golan, B Bilori in Bone Marrow Transplantation (1999)

  15. No Access

    Article

    Early fulminant leukaemia post autologous bone marrow transplantation in non-hodgkin’s lymphoma patients

    Although autologous bone marrow transplantation (ABMT) is a curative option for about 50% of the patients with progressive or relapsing Symphomas, considerable concern has been raised recently over the emergin...

    A Toren, G Rechavi, A Nagler in Medical Oncology (1998)

  16. No Access

    Chapter and Conference Paper

    PCR as a Diagnostic Tool in ALL: A Comparison Between Cytogenetic and Polymerase Chain Reaction Analysis in Pediatric Patients with Acute Lymphoblastic Leukemia

    The E2A/PBXl and the BCR/ ABL fusion genes are formed by the t(l; 19)(q23;p13) and the t(9; 22)(q34; q 11), respectively, and encode oncoproteins which are thought to play an important role in the development ...

    S. Izraeli, J. W. G. Janssen, O. A. Haas, J. Harbott, F. Brok-Simoni in Acute Leukemias IV (1994)

  17. No Access

    Chapter and Conference Paper

    Successful Central Nervous System Prophylaxis Without Radiotherapy in Childhood Acute Lymphoblastic Leukemia (ALL); Israel National Studies (INS 1984, 1989)

    Adequate early prophylactic treatment for occult central-nervous-system (CNS) leukemia is one of the key elements for successful treatment in childhood acute lymphoblastic leukemia (ALL). The classical treatme...

    B. Stark, A. Abromov, D. Attias, A. Balin, Y. Barak, Y. Goshen in Acute Leukemias IV (1994)

  18. No Access

    Article

    The management of pediatric brain tumors in a tertiary center

    Between January 1982 and January 1990,120 newly diagnosed pediatric patients were treated at The Chaim Sheba Medical Center. Sixty three (52.5%) tumors arose in the posterior fossa and 57 (47.5%) appeared supr...

    M. Mandel, A. Toren, G. Findler, Y. Neumann in Medical Oncology and Tumor Pharmacotherapy (1992)

  19. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner in Annals of Hematology (1992)